send link to app

Digihaler® app for iPhone and iPad


4.6 ( 5936 ratings )
Medical
Developer: Teva Pharmaceuticals USA, Inc.
Free
Current version: 1.5, last update: 6 months ago
First release : 28 Jun 2022
App size: 164.47 Mb

Welcome to your Digihaler® app.
This app is intended for adults who have been prescribed by their healthcare professional a Digihaler, which contains medicine.
The app allows you to view and monitor your inhaler events and technique. You can also share reports from the app with your healthcare professional (e.g. doctor, nurse).

After downloading the Digihaler App, select ‘Great Britain’ on the Country Selector screen, allow Camera permission, and scan the QR code on the top of your inhaler to unlock the App. After creating an account and pairing your Digihaler, your Digihaler will be ready to start sending data to the App. Once you start using your Digihaler (open, inhale and close the mouthpiece), your Digihaler will connect to the app, and data will be transmitted using Bluetooth wireless technology when your Digihaler is close to your smartphone.

The Digihaler app can:
- Track your inhaler events and their inspiratory flow rate classification (Five classifications: good inhalation, fair inhalation, low/no inhalation, exhalation, and possible air vent block)
- Let you know if you appear to be using your inhaler more, or less, than recommended
- Remind you when a prescription refill might be needed
- Provide local forecasts for weather and air quality
- Create reports you can share

The Instructions For Use (IFU) for the Digihaler® Mobile Application (App) are supplied in electronic form, within the App itself, instead of in paper form. A printable version of the IFU may be found on the Digihaler® patient website (https://www.tevadigihaler.co.uk). In addition, you may request the IFU in paper form, at no additional cost, by contacting your local Teva Medical Information Service. The paper IFU may be received within 7 calendar days of request.
Teva Medical Information Service can be contacted at: United Kingdom (UK)- [email protected]

Basic UDI-DI: 08600089735APPTL
iOS App UDI-DI: (01)860008973504(21)iOS1.5.0

Manufacturer contact:
Teva Respiratory LLC,
245 Main Street Flr 11,
Cambridge, MA, 2142
United States
[email protected]
207 540 7117

If you get any side effects, talk to your healthcare professional, pharmacist or nurse. This includes any possible side effects not listed in the Package Leaflet You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects, you can help provide more information on the safety of this medicine. Adverse events should also be reported to Teva UK Limited using the Reporting Side Effects Form or email [email protected] or tel 0207 540 7117.